Dyslipidemias  >>  Simvast CR (simvastatin controlled-release)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Simvast CR (simvastatin controlled-release) / Hanmi
NCT00973115: Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia

Completed
3
132
RoW
Simvastatin CR
Hanmi Pharmaceutical Company Limited
Hyperlipidemia
08/09
08/09

Download Options